3 1 Swiftmed International Ltd 11697896 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is transport activities. Digita Accounts Production Advanced 6.30.9574.0 true 11697896 2024-01-01 2024-12-31 11697896 2024-12-31 11697896 core:CurrentFinancialInstruments 2024-12-31 11697896 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 11697896 core:Non-currentFinancialInstruments 2024-12-31 11697896 core:Non-currentFinancialInstruments core:AfterOneYear 2024-12-31 11697896 core:Goodwill 2024-12-31 11697896 bus:SmallEntities 2024-01-01 2024-12-31 11697896 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 11697896 bus:FilletedAccounts 2024-01-01 2024-12-31 11697896 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 11697896 bus:RegisteredOffice 2024-01-01 2024-12-31 11697896 bus:Director1 2024-01-01 2024-12-31 11697896 bus:Director2 2024-01-01 2024-12-31 11697896 bus:Director3 2024-01-01 2024-12-31 11697896 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 11697896 bus:Agent1 2024-01-01 2024-12-31 11697896 core:Goodwill 2024-01-01 2024-12-31 11697896 countries:AllCountries 2024-01-01 2024-12-31 11697896 2023-01-01 2023-12-31 11697896 2023-12-31 11697896 core:CurrentFinancialInstruments 2023-12-31 11697896 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 11697896 core:Non-currentFinancialInstruments 2023-12-31 11697896 core:Non-currentFinancialInstruments core:AfterOneYear 2023-12-31 xbrli:pure iso4217:GBP

Registration number: 11697896

Swiftmed International Ltd

Unaudited Filleted Financial Statements

for the Year Ended 31 December 2024

 

Swiftmed International Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 8

 

Swiftmed International Ltd

Company Information

Directors

Mr Karl Glazebrook

Mr Joel Glazebrook

Mrs Ann Glazebrook

Registered office

Bridge House Pattenden Lane
Marden
Tonbridge
TN12 9QJ

Accountants

T B Tax Services Bridge House
Pattenden Lane
Marden
Kent
TN12 9QJ

 

Swiftmed International Ltd

(Registration number: 11697896)
Balance Sheet as at 31 December 2024

Note

2024
£

2023
£

Fixed assets

 

Intangible assets

4

100,000

-

Current assets

 

Debtors

5

344,614

2

Cash at bank and in hand

 

88

-

 

344,702

2

Creditors: Amounts falling due within one year

6

(145,806)

-

Net current assets

 

198,896

2

Total assets less current liabilities

 

298,896

2

Creditors: Amounts falling due after more than one year

6

(263,014)

-

Net assets

 

35,882

2

Capital and reserves

 

Called up share capital

7

3

2

Retained earnings

35,879

-

Shareholders' funds

 

35,882

2

For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 22 September 2025 and signed on its behalf by:
 

 

Swiftmed International Ltd

(Registration number: 11697896)
Balance Sheet as at 31 December 2024

.........................................
Mr Karl Glazebrook
Director

.........................................
Mr Joel Glazebrook
Director

 

Swiftmed International Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

1

General information

The company is a private company limited by share capital, incorporated in UK.

The address of its registered office is:
Bridge House Pattenden Lane
Marden
Tonbridge
TN12 9QJ
England

These financial statements were authorised for issue by the Board on 22 September 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Swiftmed International Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

 

Swiftmed International Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2023 - 1).

 

Swiftmed International Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

4

Intangible assets

Goodwill
 £

Total
£

Cost or valuation

Additions acquired separately

100,000

100,000

At 31 December 2024

100,000

100,000

Amortisation

Carrying amount

At 31 December 2024

100,000

100,000

5

Debtors

Current

2024
£

2023
£

Other debtors

344,614

2

 

344,614

2

6

Creditors

Creditors: amounts falling due within one year

2024
£

2023
£

Due within one year

Trade creditors

878

-

Taxation and social security

39,116

-

Accruals and deferred income

105,812

-

145,806

-

Creditors: amounts falling due after more than one year

Note

2024
£

2023
£

Due after one year

 

Loans and borrowings

8

99,997

-

Other non-current financial liabilities

 

163,017

-

 

263,014

-

 

Swiftmed International Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

7

Share capital

8

Loans and borrowings

Non-current loans and borrowings

2024
£

2023
£

Other borrowings

99,997

-

9

Dividends